Neupulse has secured £2.5 million funding to commercialise the world’s first wearable device to t...
TruSpine Technologies Plc is eyeing a ‘new future’ after shaking up its board and securing poten...
Oxford BioDynamics PLC has raised £9.9 million in a new share placing. The MedTech company, behi...
BenevolentAI's new CEO Dr Joerg Moeller has reported the company's 2023 results. The London-headq...
Manchester-based Phagenesis has raised £33 million in a Series D funding round. The medical devi...
Chancellor Jeremy Hunt has announced a ‘significant’ investment package in the UK’s life scien...
TrakCel is expanding its OCELLOS partner ecosystem, which will bring the total number of integrated ...
Curve Therapeutics has raised £40.5 million in Series A financing to develop breakthrough cancer tr...
NATROX® O₂, a continuous topical oxygen therapy, is gaining attention for its potential role in m...
Alginate is the most commonly-used impression material for fabricating study models, creating antago...
IsomAb - a University of Nottingham spinout pioneering a new treatment for diabetics at risk of ampu...
MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate th...